Pipeline

June 28, 2021

Company	Drug/Device	Medical Condition	Status
Nanoscope Therapeutics	MCO-010	advanced retinitis pigmentosa	IND approved by the FDA for a phase 2b trial
Hope Biosciences Stem Cell Research Foundation	intravenous infusions of allogeneic adipose-derived mesenchymal stem cells	Parkinson’s disease	IND approved by the FDA for a phase 2 trial
Prestige Biopharma	PBP1510	pancreatic cancer	clinical trial authorized by the French National Agency for the Safety of Medicines and Health Products for a phase 1/2 trial
Roche	cobas SARS-CoV-2 nucleic acid test for use on the cobas Liat System	RT-PCR test to identify SARS-CoV-2 infection	Emergency Use Authorization granted by the FDA
Boehringer Ingelheim	Pradaxa (dabigatran etexilate) oral pellets and capsules	venous thromboembolism in children three months to less than 12 years old	approved by the FDA for expanded indication and new formulations
Becton, Dickinson and Company	PeritX peritoneal catheter system	drainage of symptomatic, recurrent nonmalignant ascites	approved by the FDA
CoreLink	F3D corpectomy vertebral body replacement system	replacement of damaged vertebral bodies in the cervical and thoracolumbar spine	approved by the FDA
Fist Assist Devices	FA-1 device	focal arm massage and increased arm vein circulation	approved by the FDA
Onkos Surgical	Eleos limb salvage system	to support bone in-growth in musculoskeletal oncology and complex orthopedic limb salvage cases	approved by the FDA
Integrity Implants	FlareHawk expandable lumbar interbody fusion device	spinal intervertebral body fusion	approved in the European Union
AstraZeneca HutchMed	savolitinib	treatment of patients with nonsmall-cell lung cancer with MET exon 14 skipping alterations who have progressed following prior systemic therapy or are unable to receive chemotherapy	approved in China
Beigene	tislelizumab	first-line treatment of advanced nonsquamous, nonsmall-cell lung cancer and patients with hepatocellular carcinoma who have been previously treated with at least one systemic therapy	approved in China
Fosun Kite Biotechnology	axicabtagene ciloleucel	treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy	approved in China
Amgen	Aimovig (erenumab)	suppression of onset of migraine attacks in adults	approved in Japan
CardioFocus	HeartLight X3 system	catheter ablation for controlled and consistent pulmonary vein isolation	approved in Japan
Poxel Sumitomo Dainippon Pharma	Twymeeg (imeglimin hydrochloride)	type 2 diabetes	approved in Japan